Cologuard Plus test receives FDA approval, understanding genomic profiling leads to advanced personalized care in breast cancer, and a new CAR T therapy is making waves in multiple myeloma.
The FDA has approved the Cologuard Plus test, a noninvasive stool DNA test to screen adults 45 and older at average risk for colorectal cancer (CRC). 1 “To meaningfully improve outcomes in colorectal ...
Digital card and casino-style table games are usually presented to players without a lot of extra flair. Even videogame-first iterations of card games like Balatro, Card Shark, or Stacklands ...
Occasional changes in stool (poop) colors usually occur as a result of the food you eat. A persistent change in the color of your stool could also indicate an underlying health condition and ...